Trials / Terminated
TerminatedNCT03328598
A Community-based Resilience Program of Only-child Loss Parents
Implementation of a Community-based Resilience Promotion Program to Only-child Loss Parents in China
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 144 (actual)
- Sponsor
- Central South University · Academic / Other
- Sex
- All
- Age
- 49 Years
- Healthy volunteers
- Accepted
Summary
This is a community-based participatory research aiming at helping the only-child loss parents to be happier and resilient from bereavement. It is a psycho-behavioral intervention research. There are two intervention programs in this study. One is derived from a foreign psychotherapy, developed by an American psychologist and has been testified the effectiveness in promoting happiness. Another one is developed by the researchers based on the previous cross-sectional survey and interviews with those bereaved parents. The researchers will apply randomized controlled trial to testify and compare those two intervention programs in a Chinese community.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Positive psychology therapy group | This program is developed from a foreign group program based on positive psychology. The positive psychology therapy lasts 8 weeks, and has a group intervention in each week. The themes of each week are start-up, time gift, positive mind, three good things, a thankful heart, life train, active service, end-up. |
| BEHAVIORAL | Resilience promotion therapy group | The other one is developed from research team's previous research results. The resilience promotion therapy lasts 8 weeks, and also has a group intervention in each week. The themes of each week are start-up, mutual help, trust in yourself, thanksgiving feedback, care for yourself, emotional management, end-up. |
| OTHER | Controlled routine activity | Conventional community activities is viewed as an active comparator for controlled group. |
Timeline
- Start date
- 2017-12-01
- Primary completion
- 2018-01-24
- Completion
- 2019-01-31
- First posted
- 2017-11-01
- Last updated
- 2023-08-30
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03328598. Inclusion in this directory is not an endorsement.